AIHealthcare

Mendaera, Inc. is a privately held healthcare technology and medical robotics company developing a handheld robotic interventional platform that combines robotics, real-time imaging—particularly ultrasound—artificial intelligence, and connectivity. Its technology is intended to support precise, consistent, image-guided needle-based procedures, including vascular access, biopsies, organ access, regional anesthesia, neuraxial blocks, and pain-management interventions. Mendaera positions itself as creating a distinct category of compact, scalable interventional robotics for use across hospitals, ambulatory surgical centers, interventional radiology and catheterization labs, and eventually broader points of care. The company’s stated market objective is to digitize clinical judgment and technical expertise, expand access to procedural care, and reduce variability between providers. It remains a private, emerging medical-device company; independently verified market-share or revenue data was not available. Mendaera’s website reports more than $130 million raised to date, while several third-party databases report approximately $97 million across two publicly disclosed rounds, so the precise cumulative total is not independently reconciled.